Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-acetylglucosamine-1-phosphate transferase subunit gamma (GNPTG) is the non-catalytic gamma subunit of the hexameric N-acetylglucosamine-1-phosphotransferase complex, which is essential for targeting lysosomal hydrolases to the lysosome through the synthesis of mannose 6-phosphate (M6P) recognition markers. GNPTG acts as an accessory protein with a mannose-6-phosphate receptor homology (MRH) domain that assists substrate glycan binding and presentation to the GNPTAB catalytic subunits, influencing enzymatic specificity and efficiency. Genetic defects in GNPTG cause mucolipidosis type IIIC (mucolipidosis III gamma), a lysosomal storage disorder characterized by mislocalization of lysosomal enzymes[1][3][4]. The gamma subunit is not sufficient for catalysis but is required for the proper function of the complex on certain lysosomal hydrolase substrates and enhances the addition of multiple phospho-GlcNAc groups to pathway glycans[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-acetylglucosamine-1-phosphate transferase subunit gamma (GNPTG).